Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Depreciation & Amortization (CF): 2010-2019

Historic Depreciation & Amortization (CF) for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Dec 2019 value amounting to $3,000.

  • EyePoint Pharmaceuticals' Depreciation & Amortization (CF) rose 110.00% to $3,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $60,000, marking a year-over-year decrease of 57.14%. This contributed to the annual value of $1.5 million for FY2024, which is 208.00% up from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Depreciation & Amortization (CF) of $3,000 as of Q4 2019, which was down 93.18% from $44,000 recorded in Q1 2019.
  • Over the past 5 years, EyePoint Pharmaceuticals' Depreciation & Amortization (CF) peaked at $84,000 during Q2 2018, and registered a low of -$30,000 during Q4 2018.
  • For the 3-year period, EyePoint Pharmaceuticals' Depreciation & Amortization (CF) averaged around $32,900, with its median value being $41,000 (2017).
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Depreciation & Amortization (CF) spiked by 550.00% in 2017 and then tumbled by 168.18% in 2018.
  • Over the past 5 years, EyePoint Pharmaceuticals' Depreciation & Amortization (CF) (Quarterly) stood at $30,000 in 2015, then declined by 13.33% to $26,000 in 2016, then spiked by 69.23% to $44,000 in 2017, then crashed by 168.18% to -$30,000 in 2018, then spiked by 110.00% to $3,000 in 2019.
  • Its last three reported values are $3,000 in Q4 2019, $44,000 for Q1 2019, and -$30,000 during Q4 2018.